Cervical cancer can be successfully prevented or mitigated through routine cervical cancer screening. However, a significant disparity in screening exists in the Muslim American women population due to societal pressures, healthcare inequities, and a lack of recognition as a disparate community. This review explores these barriers and strategies in addressing them, to ultimately aims raise awareness of the health disparities of Muslim American women.
Outside of the 16% of male-directed contraceptive techniques, contraception seems to primarily rely on the cooperation of females. As discussed by Medical Anthropologist Emily Martin in her rhetorical analysis, “The Egg and the Sperm”, an apparent history of gender stereotypes has been hidden and unaddressed in scientific research. At first glance, such stereotypes may not seem obvious; however, the disparity of gendered-contraception reveals a clear disproportion of social perspective on sex and responsibility. Both men and women are limited by the options of contraception in different ways, which may be fueled by societal biases in marketing and research.
As genetic testing grows in popularity, researchers have begun identifying specific alleles in the human genome related to a heritable aspect of endometriosis, a condition that affects more than one in ten women of reproductive age. Researchers are working to identify specific genetic biomarkers to more accurately diagnose and eventually treat endometriosis. This review will focus on new genetic biomarkers and their role in potential non-invasive diagnostic and possible treatment options.
Polycystic Ovary Syndrome (PCOS) is one of the most common disorders diagnosed in women. It is characterized by menstrual irregularities, hyperandrogenism, and infertility. A solidified reason as to why so many women develop PCOS has not yet been identified, but research suggests a significant connection with Endocrine Disrupting Chemicals (EDCs). This review will examine the relationship between PCOS onset and bodily concentrations of one EDC: Bisphenol A.
Approximately 10% of reproductive-age biological women struggle with endometriosis, a debilitating uterine condition characterized by the atypical growth of endometrial tissue that causes various symptoms from extreme menstruation pain to decreased fertility. Unfortunately, current pharmaceutical treatment options are associated with a variety of toxic side effects and continue to raise uncertainty about their efficacy. Recent emerging research suggests that the drug dienogest may be a noteworthy competitor with fewer side effects. This review evaluates the efficacy of dienogest as a treatment for endometriosis.
In the past century, the two most prominent causes of death have been heart disease and cancer [1]. Heart disease disproportionately affects older adults, and cancer typically follows a similar pattern. One exception to this is testicular cancer, which in contrast to most types of cancer, occurs most often in 25-45 year old males [2, 3]. Another defining feature of testicular cancer is the extremely high ...
